Truist Financial
PBYI icon

Truist Financial’s Puma Biotechnology PBYI Stock Holding History

Truist Financial’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-109,902
Closed -$770K – 2827
2021
Q3 		$770K Buy
109,902
+1,667
+2% +$12.5K ﹤0.01% 1752
2021
Q2 		$994K Buy
108,235
+7,009
+7% +$71K ﹤0.01% 1660
2021
Q1 		$984K Buy
101,226
+43,867
+76% +$490K ﹤0.01% 1604
2020
Q4 		$589K Buy
57,359
+14,638
+34% +$148K ﹤0.01% 1775
2020
Q3 		$431K Buy
42,721
+8,339
+24% +$84.9K ﹤0.01% 1803
2020
Q2 		$359K Buy
34,382
+3,149
+10% +$32.6K ﹤0.01% 1824
2020
Q1 		$264K Buy
31,233
+13,463
+76% +$131K ﹤0.01% 1939
2019
Q4 		$155K Buy
+17,770
New +$147K ﹤0.01% 2387

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return